Alum Lieza Danan, CEO and co-founder of LiVeritas Biosciences, discusses her journey in startups and life, including her years at UC Davis, where she earned a Ph.D. degree in biological chemistry in 2009.
New research shows that the anti-anxiety and hallucinogenic-like effects of a psychedelic drug work through different neural circuits. The study, in a mouse model, shows that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.
Tatiana Mamani, a Ph.D. candidate in physical chemistry working with Professor of Chemistry Davide Donadio, is among 62 Ph.D. students selected nationwide to participate in Department of Energy's Office of Science Graduate Student Research program.
Our bodies are pharmaceutical factories, but did you know that our bodies also naturally produce psychedelics? Why do we make them? How do they work? What are their functions? And can we leverage them to mitigate neurodegenerative and neuropsychiatric conditions? The UC Davis Institute for Psychedelics and Neurotherapeutics is exploring those questions.
Design2Data, or D2D, provides undergraduate students with early laboratory experiences learning about enzymes and related protein structures with findings that contribute to a national network of data.
Almost three years after breaking ground, the Chemistry Building’s new addition opened its doors at the beginning of September — just in time for fall quarter.
At the College of Letters and Science at UC Davis, researchers are using the power of machine learning to help protect us from the next pandemic, discover and build new materials, and explore the myriad galaxies in the heavens above.
In "CHE 125 — Advanced Methods in Physical Chemistry," undergraduate students apply advanced theory and laboratory techniques to personal research projects that they complete in a 10-week time frame
